An update on Herbal Products for the Management of Inflammatory Bowel Disease.
Himanshu AryaRameshwar DassBhawna ChopraPriyanka KriplaniGeeta DeswalAjmer Singh GrewalAshwani Kumar DhingraSuresh KumarPublished in: Anti-inflammatory & anti-allergy agents in medicinal chemistry (2023)
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a continuously increasing healthcare problem mainly characterized by chronic relapsing intestinal inflammation. The common symptoms of UC and CD include inflammation, diarrhea, abdominal pain, bleeding, and weight loss. IBD is generally caused by an interaction between genetic and environmental or microbial factors that influence the body's immune response and is responsible for digestive disorders and inflammation of the intestinal tract. However, a complete understanding of the pathophysiology and work-up of IBD is necessary to ensure appropriate treatment for the management of this complex disease. This review enlightens herbal therapeutics and drug delivery systems for the management of IBD, and thus provides new insights into this field and facilitates access to new treatments.
Keyphrases
- ulcerative colitis
- oxidative stress
- healthcare
- immune response
- weight loss
- abdominal pain
- multiple sclerosis
- bariatric surgery
- gene expression
- rheumatoid arthritis
- small molecule
- microbial community
- insulin resistance
- risk assessment
- dendritic cells
- adipose tissue
- toll like receptor
- copy number
- genome wide
- sleep quality
- gastric bypass
- nk cells
- obese patients